We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last …
REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s Read More »
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. This week the …
JC: Aspirin is not effective for hospitalised COVID19 patients. St Emlyn’s Read More »
The prevention of venous thromboembolism (VTE) has been a real concern in the management of hospitalised patients with COVID-19. We have previously discussed the role of prophylactic anticoagulation (thromboprophylaxis) for …
JC: Thromboprophylaxis on the ICU for COVID-19 patients. St Emlyn’s Read More »
Our regular podcast round up from February 2021. Iain and Simon highlight the key learning points from this month on the St Emlyn’s blog and podcast. Please remember to subscribe …
The latest results on the use of convalescent plasma in Covid-19 are now out from the RECOVERY trial as a pre-print. As you know we have already covered the trial …
JC: Convalescent plasma (still) does not work in COVID-19. St Emlyn’s Read More »
This week the RECOVERY trial has released the first results from the Colchicine arm of the trial. We await the pre-print and the peer reviewed paper, but we are already …
Colchicine does not improve mortality in COVID19. St Emlyn’s Read More »
It’s very rare we produce three instalments on one particular drug for one particular condition, and certainly not within such a short time frame. However, tocilizumab has been worth it. …
Tocilizumabulous? A special offer on IL-6 with Tocilizumab. Read More »
In arguably the most important therapeutic news of the pandemic since Dexamethasone, the RECOVERY trial investigators have revealed the initial results on the Tocilizumab arm of the trial showing a …
JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s Read More »
Hot on the heels of a terrific pun and blog post about the use of Tocilizumab, capturing all the intrigue, hope and caution with the potential use of this novel therapeutic …
Tocilizumorelikeit? The latest data on Tocilizumab. St Emlyn’s Read More »
We have been following the RECOVERY trial closely over the last few months. It’s the largest RCT of therapeutics for COVID-19 in the world and it’s already shown that hydroxychloroquine …
JC: Lopinavir/Ritonavir in the treatment of COVID-19 Read More »